Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

CAN (ON): Eve & Co. enters LOI with Dr. Kerklaan Therapeutics

Eve & Co's wholly-owned subsidiary, Natural MedCo has entered into an exclusive letter of intent (“LOI”) with ECS BioMed Inc. (“Dr. Kerklaan Therapeutics”) effective January 14, 2020. The LOI contemplates the exclusive right and license to manufacture, import and export, warehouse, package, advertise, market, distribute and sell the following products in Canada under the Dr. Kerklaan Therapeutics brand, under the Eve & Co brand, or as co-branded products under the Eve & Co and Dr. Kerklaan Therapeutics brands: Natural CBD Relief Cream, Natural CBD Relief Stick, Natural CBD Spray, Natural CBD Sleep Cream, Natural CBD Skin Cream, and Natural CBD PMS Cream.

"The LOI contemplates Natural MedCo and Dr. Kerklaan Therapeutics entering into a licensing agreement by May 13, 2020," the team with the company explains. "The term of the proposed license agreement is for an initial five years commencing January 14, 2020, with Natural MedCo having the option to extend the term in five year intervals. The Company anticipates manufacturing and distributing CBD-infused topicals to the Canadian market in 2020.

Melinda Rombouts, President and CEO of Eve & Co commented, “We are very excited to be partnering with Dr. Kerklaan Therapeutics on the development and distribution of CBD Creams. Dr. Kerklaan and his team have brought their extensive knowledge of the CBD industry and unparalleled enthusiasm to the table, and we are eager to move forward together and capture the potential for both companies in Canada.” Ms. Rombouts continued, “Dr. Kerklaan has developed many high-end CBD topical products which address a number of concerns and are a complementary fit for our brand, Eve.”

“Canada represents an exciting opportunity for Dr. Kerklaan Therapeutics. Expanding our international reach to include Canada is an important milestone for the brand, and we’re thrilled to have Eve & Co as a strategic partner to help launch our collection of CBD topicals,” said Dr. Kerklaan, Founder & CEO of Dr. Kerklaan Therapeutics.

For more information:
Eve & Co. 
+1 (833) EVE-CANN   

Publication date: